Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Plus Therapeutics Inc PSTV

Healthcare Biotechnology
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers. The Company combines image-guided local beta radiation and targeted drug delivery approaches. The Company is advancing a pipeline of product candidates with lead programs in recurrent glioblastoma... see more

Recent & Breaking News (NDAQ:PSTV)

Cytori to Webcast at the Future Leaders in the Biotech Industry Conference on April 5, 2013

Business Wire March 29, 2013

Cytori Patents Method of Treating Renal Diseases Using Adipose-Derived Regenerative Cells

Business Wire March 28, 2013

Cytori Provides Update in 510(k) Appeal Decision

Business Wire March 22, 2013

Cytori Therapeutics To Present at the 25th Annual Roth Conference on March 18

Business Wire March 11, 2013

Cytori Reports 2012 Business and Financial Results; Provides Outlook for 2013

Business Wire March 7, 2013

Cytori to Webcast Fourth Quarter and Year End Financial Results on March 7

Business Wire February 28, 2013

Cytori Appoints Dr. Steven Kesten as Executive Vice President and Chief Medical Officer

Business Wire February 26, 2013

Intravase® Approval Opens Vascular Market for Cytori

Business Wire February 25, 2013

Mergers and Acquisitions on the Rise in 2013 as Big Pharma Companies Hold Record Amounts of Cash on Hand

Marketwired January 24, 2013

Cytori Announces Presentation at Biotech Showcase(tm) on January 8th

Business Wire January 4, 2013